Aecom vs Novartis AG — how do they compare? Aecom trades at $67.13 (market cap $8.62B), while Novartis AG trades at $152.33 (market cap $295.37B). The key difference: Novartis AG is far larger — about 34.3× Aecom's market cap, and Novartis AG pays the higher dividend (3.07%). Which is the better fit depends on your goals.
| ACM | NVS | |
|---|---|---|
Market Cap | $8.62B | $295.37B |
Sector | Industrials | Health |
52-Week High | $134.35 | $168.62 |
52-Week Low | $66.86 | $119.31 |
Enterprise Value | $10.81B | $336.69B |
Dividend Yield | 1.77% | 3.07% |
Trailing returns across standard periods
Latest headlines on both assets
Aecom is one of the largest global providers of design, engineering, construction, and management services. The firm serves a broad spectrum of end markets including infrastructure, water, transportation, and energy. Based in Los Angeles, Aecom has a presence in over 150 countries and employs 51,000. The company generated $13.3 billion in sales and $701 million in adjusted operating income in fiscal 2021.
Read more on ACM →Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →